QUANTGROUP (02685.HK): Unit to Supply Up to 2,000 AI Robots by End-2027 Under Framework Deal
NewTimeSpace News: On 25 October 2026, Quantgroup Holding Limited (stock code: 2685) published a voluntary announcement that its wholly-owned subsidiary Siji (Beijing) Intelligent Technology Development Co., Ltd. (矽基智能) signed a framework procurement and scenario-enablement strategic cooperation agreement on 23 October 2026 with Chewujie (Beijing) Automobile Co., Ltd. (车无界(北京)), a Beijing-registered car dealership. To the best of the directors' knowledge, Chewujie (Beijing) and its ultimate beneficial owners are independent third parties.
Under the agreement, Siji Intelligent will provide up to 2,000 one-stop solutions by the end of 2027, comprising physical AI robots, embedded software, automotive sales scenario configuration and supporting services, for use in car dealership stores managed by Chewujie (Beijing). Covered scenarios include customer greeting and reception, model introduction, customer interaction, and lead collection and distribution; supporting services include knowledge base configuration, sales script and workflow customisation, system integration, training, operational support and remote maintenance.
The cumulative procurement cap is 2,000 units, with phased confirmation and delivery. Specific models, configurations, software modules, after-sales service, delivery stores and prices will be proposed by Chewujie (Beijing) according to store needs and agreed in final purchase confirmations. The planned volumes are indicative only and create no binding delivery obligation; the agreement is a framework agreement and is not legally binding on either party.
The board considers the agreement an application of the Group's "AI + consumer scenarios" strategy in the physical world and an extension of its existing AI capabilities, and not a material change to its principal business. The cooperation may not materialise, and the Company will make further announcements if definitive agreements are signed or material progress is made.
- SKB BIO (06990.HK): ESMO Data for Sac-TMT in Two Phase III Lung Cancer Studies
- CSTONE PHARMA-B (02616.HK): CS2009 Data in 300+ Patients at ESMO; 100% ORR in 1L NSCLC Cohort
- LEADS BIOLABS-B (09887.HK): Updated LBL-034 Data in RRMM Presented at ESMO
- MICROINTELLIGENCE (03275.HK): Delays Global Offering and Listing; Application Monies to Be Refunded
- CHINA SHENHUA (01088.HK): Acquires 50% of Guoneng Xinjiang Coal-to-Gas for RMB617.7m